Evidence map›Paper›PMID 32797382›Full record

ReviewCurrent HIV/AIDS reports2020

Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.

Shahin Lockman, Molly Pretorius Holme, Joseph Makhema, Pamela Bachanas, Janet Moore, Kathleen E Wirth, Refeletswe Lebelonyane, M Essex

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01965470 (Botswana Combination Prevention Project), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01965470 phase4completednot on this map

Botswana Combination Prevention Project: -Evaluation Protocol (Protocol #1): Research Design and Impact Evaluation -Closed Clinical Cohort Protocol (Protocol #3) Implementation, Monitoring and Evaluation of Combination HIV Prevention Interventions in Rural and Peri-Urban Communities in Botswana

TypeinterventionalSponsorCenters for Disease Control and PreventionRan2013 to 2018ConditionsHIVArmsCombination Prevention, Enhanced Care
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shahin LockmanBrigham and Women's Hospital, PBB-A4, 15 Francis Street, Boston, MA, 02115, USA. slockman@hsph.harvard.edu.
Molly Pretorius HolmeHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Joseph MakhemaHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Pamela BachanasCenters for Disease Control and Prevention, Atlanta, GA, USA.
Janet MooreCenters for Disease Control and Prevention, Atlanta, GA, USA.
Kathleen E WirthHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Refeletswe LebelonyaneMinistry of Health and Wellness, Gaborone, Botswana.
M EssexHarvard T.H. Chan School of Public Health, Boston, MA, USA.

Funding

CGH CDC HHS U01 GH000447CGH CDC HHS U2G GH000073CGH CDC HHS U2G GH000227CGH CDC HHS U2G GH000419CGH CDC HHS U2G GH001911PEPFAR
6 · The paper itself

Abstract

purpose of reviewAntiretroviral treatment (ART) can dramatically reduce the risk of HIV transmission, but the feasibility of scaling up HIV testing, linkage and treatment to very high population levels, and its impact on population HIV incidence, were unknown. We review key findings from a community-randomized trial in which we evaluated the impact of "universal test and treat" (UTT) on population HIV incidence in Botswana, a resource-constrained country with both high HIV prevalence and high ART coverage before study inception. RECENT

findingsWe conducted a community-randomized trial (the "Ya Tsie" trial or Botswana Combination Prevention Project (BCPP)) in 30 villages in Botswana from 2013 to 2018, with the goal of determining whether a combination of prevention interventions-with a focus on universal HIV testing and treatment-would reduce population-level HIV incidence. The intervention included universal HIV testing (home-based and mobile), active linkage to HIV care and treatment with patient tracing for persons not linking, universal ART coverage, rapid ART start (at the first clinic visit), and enhanced male circumcision services. Botswana had very high HIV diagnosis, treatment, and viral suppression levels (approaching the UNAIDS "90-90-90" targets) prior to intervention roll-out. By study end, we were able to exceed the overall 95-95-95 coverage target of 86%: an estimated 88% of all persons living with HIV were on ART and had viral suppression in the Ya Tsie intervention arm. In addition, annual HIV incidence was 30% lower in the intervention arm as compared with the control arm over a 29-month follow-up period. With universal HIV testing and relatively simple linkage activities, it was possible to achieve one of the highest reported population levels of HIV diagnosis, linkage to care, and viral suppression globally and to reduce population HIV incidence by about one-third over a short period of time (< 3 years). We were able to significantly increase population viral suppression and to decrease HIV incidence even in a resource-constrained setting with pre-existing very high testing and treatment coverage. Universal community-based HIV testing and tracing of individuals through the HIV care cascade were key intervention components.

Indexed as

AdultAnti-Retroviral AgentsBotswanaCircumcision, MaleContact TracingFemaleHIV InfectionsHIV TestingHumansIncidenceMaleMass ScreeningPrevalencePublic HealthAnti-Retroviral AgentsBotswanaCombination preventionHIVTreatment as preventionUniversal testing and treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.